Oppenheimer Upgrades Edwards Lifesciences (EW) to Outperform, 'Transcatheter Tricuspid an Exciting Opportunity on the Horizon'
Tweet Send to a Friend
(Updated - September 26, 2023 6:03 AM EDT)
Oppenheimer analyst Suraj Kalia upgraded Edwards Lifesciences (NYSE: EW) from Perform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Suraj Kalia upgraded Edwards Lifesciences (NYSE: EW) from Perform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
